GLP-3 Research Guide
An investigational triple agonist of the glucagon, GIP and GLP-1 receptors, supplied as ZL-R10 and ZL-R20. Covers the receptor pharmacology and the preclinical cell and animal research.
What is GLP-3?
GLP-3 is the research peptide We supply as ZL-R10 (10 mg per vial) and ZL-R20 (20 mg per vial). Both vials hold the same material; only the amount per vial differs. It is an investigational synthetic peptide designed as a single molecule with agonist activity at three receptors: the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R) (Coskun et al., 2022).
That places it in the incretin receptor research field as a “triple agonist”, one step beyond single GLP-1 receptor agonists and dual GIP and GLP-1 receptor agonists. Researchers study it to understand how adding glucagon receptor activity changes the metabolic effects seen with incretin receptor agonism alone.
Research areas studied
The findings below come from published cell-based and animal research. They describe what studies have examined and reported, not effects of any research material.
Receptor activity in vitro
In the discovery report, in vitro assays showed balanced GCGR and GLP-1R activity with greater activity at GIPR (Coskun et al., 2022). The authors proposed that glucagon receptor activity could add an increase in energy expenditure on top of the reduced calorie intake associated with GIP and GLP-1 receptor activity.
Animal studies
In obese mice, administration of the compound decreased body weight and improved glycemic measures. The investigators reported that the added body weight effect was linked to GCGR-mediated increases in energy expenditure (Coskun et al., 2022).
Regulatory status and limits of the evidence
In the sources reviewed for our Research Library, the molecule is investigational and has not been approved by the FDA or any other regulatory authority. The research summarized here was carried out in cell-based assays and animal models under laboratory conditions. Those results do not establish the identity, equivalence or properties of any research material, which is why each lot should be judged on its own analytical documentation.
Storage and handling
Like most research peptides, GLP-3 is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.
When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.
Quality and COA
Every Zero Zero Collection product page has a View COA link. Certificates of analysis come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page where available. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.
GLP-3 FAQ
Are ZL-R10 and ZL-R20 the same material?
Yes. Both contain GLP-3, the research peptide described in this guide. ZL-R10 holds 10 mg per vial and ZL-R20 holds 20 mg per vial.
Which receptors does GLP-3 act on?
Published research describes it as an agonist at the glucagon, GIP and GLP-1 receptors, with balanced glucagon and GLP-1 receptor activity and greater GIP receptor activity in vitro.
Is GLP-3 an approved drug?
No. In the sources we reviewed it is an investigational molecule and has not been approved by the FDA or any other regulator.
How should ZL-R10 and ZL-R20 be stored?
Keep vials refrigerated at 2 to 8 ยฐC and protected from light, as listed on both product pages.
References
- Coskun T, Urva S, Roell WC, et al. (2022). Cell Metab. PubMed 35985340
For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.